This site is intended for US Healthcare Professionals only.
To report an adverse reaction or product complaint, call 1-888-BLUPRNT, option 2, or visit or contact the FDA at 1-800-FDA-1088 or

Educational resources for healthcare professionals (HCPs)

The following resources are included only as a reference for HCPs for their practice, and do not imply endorsement of the company or its products by the groups listed.

Blueprint Medicines Resources

Advanced systemic mastocytosis and rare diseases

What Is Systemic Mastocytosis (SM)?

Gastrointestinal stromal tumor

GIST Unmet Need Micro Deck

Lung and thyroid cancer

NSCLC and TC Disease State Micro Deck

Lung and thyroid cancer

What Is EGFR-positive NSCLC?

Non-Blueprint Medicines Resources

Advanced systemic mastocytosis and rare diseases

NIH Systemic Mastocytosis Information Center

Guideline recommendations

NCCN Guidelines

EGFR, epidermal growth factor receptor; GIST, gastrointestinal stromal tumor; NCCN, National Comprehensive Cancer Network; NIH, National Institutes of Health; NSCLC, non-small cell lung cancer; SEER, Surveillance, Epidemiology, and End Results; TC, thyroid cancer.

Contact Blueprint Medicines

Blueprint Medicines is a pharmaceutical company focusing on the research, development, and commercialization of products in oncology, hematology, and rare diseases. This website is for US healthcare professionals for educational purposes only. Scientific information and data may include investigational use(s) of compounds for which efficacy and safety have not been established. Blueprint Medicines does not promote or endorse the use of its products in a manner not consistent with the approved label.